Treatment patterns and achievement of the treat-to-target goals in a real-life rheumatoid arthritis patient cohort: data from 1317 patients.
Konstantinos ThomasArgiro LazariniEvripidis KaltsonoudisAlexandros DrososIoannis PapalopoulosProdromos SidiropoulosPanagiota TsatsaniSousana GaziLina PantaziKyriaki A BokiPelagia KatsimbriDimitrios BoumpasKalliopi FragkiadakiMaria G G TektonidouPetros P SfikakisKonstantina KaragianniLazaros I SakkasEleftheria P GrikaPanagiotis G VlachoyiannopoulosGerasimos EvangelatosAlexios IliopoulosTheodoros DimitroulasAlexandros GaryfallosKonstantinos MelissaropoulosPanagiotis GeorgiouMaria AretiConstantinos GeorganasPeriklis VounotrypidisGeorge D KitasDimitrios VassilopoulosPublished in: Therapeutic advances in musculoskeletal disease (2020)
In a real-life RA cohort, during 1 year of follow-up, 43% of patients do not reach treatment targets while only ~20% of those with active RA started or switched their bDMARDs. Male sex, younger age, lower HAQ, body mass index and co-morbidity index were independent factors associated with LDA while use of GCs or ⩾2 bDMARDs were negative predictors.